GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427104. A total of 57 filers reported holding GENOCEA BIOSCIENCES INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $20,000 | -95.5% | 70,068 | -87.7% | 0.00% | -100.0% |
| Q3 2018 | $443,000 | -39.3% | 567,989 | -33.4% | 0.00% | 0.0% |
| Q2 2018 | $730,000 | +403.4% | 853,385 | +581.6% | 0.00% | – |
| Q4 2017 | $145,000 | -54.8% | 125,198 | +137.8% | 0.00% | -100.0% |
| Q1 2017 | $321,000 | +7.7% | 52,647 | -27.2% | 0.00% | 0.0% |
| Q4 2016 | $298,000 | -42.6% | 72,287 | -28.7% | 0.00% | 0.0% |
| Q3 2016 | $519,000 | -24.0% | 101,400 | -39.1% | 0.00% | -50.0% |
| Q2 2016 | $683,000 | +324.2% | 166,588 | +700.2% | 0.00% | – |
| Q1 2016 | $161,000 | -81.3% | 20,818 | -87.2% | 0.00% | -100.0% |
| Q4 2015 | $860,000 | -81.4% | 163,105 | -75.9% | 0.00% | -77.8% |
| Q3 2015 | $4,636,000 | -24.1% | 676,833 | +52.1% | 0.01% | -25.0% |
| Q2 2015 | $6,110,000 | +160.1% | 445,022 | +124.7% | 0.01% | +200.0% |
| Q1 2015 | $2,349,000 | – | 198,092 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 25,000,000 | $21,250,000 | 1.00% |
| Polaris Venture Management Co. V, L.L.C. | 1,968,606 | $1,685,000 | 0.92% |
| Vivo Capital, LLC | 8,180,000 | $7,000,000 | 0.90% |
| Ghost Tree Capital, LLC | 3,525,000 | $3,016,000 | 0.89% |
| BVF INC/IL | 5,265,000 | $4,505,000 | 0.44% |
| Birchview Capital, LP | 189,000 | $162,000 | 0.11% |
| Quinn Opportunity Partners LLC | 113,100 | $97,000 | 0.01% |
| Centiva Capital, LP | 72,234 | $62,000 | 0.01% |
| DRW Securities, LLC | 240,000 | $205,000 | 0.01% |
| Alyeska Investment Group, L.P. | 1,603,085 | $1,372,000 | 0.01% |